Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Nina Cooperman

Biographic Data

ID6076901
NAMENina Cooperman
GIVEN NAMESNina
FAMILY NAMECooperman
SIGNATURECOOPERMAN N
AFFILIATIONSThe authors are with the University of Medicine and Dentistry of New Jersey–Robert Wood Johnson Medical School, New Brunswick.
VERIFIEDNo
TOTAL WORKS4
TOTAL CITATIONS5
WORKS AS AUTHOR4
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2013
LATEST PUBLICATION YEAR2021
H-INDEX1
  • Predictors of intentional fentanyl use

    Open Access•Ralph Foglia, Nina Cooperman et al.•ARTICLE•International Journal of Drug…•2021

  • Opioid overdose in the age of fentanyl

    Open Access•Annette Kline, Anna Kline et al.•ARTICLE•International Journal of Drug…•2021

  • “A Blessing and a Curse

    Annette Kline, Anna Kline et al.•ARTICLE•Substance Use & Misuse•2020

    Background: To address the alarming rise in opioid overdose deaths, states have increased public access to the overdose reversal medication, naloxone. While some studies suggest that increased naloxone accessibility reduces opioid overdose deaths, others raise concerns about unintended consequences, such as increases in risky drug use and opioid re-use post-overdose to counter naloxone-induced withdrawal symptoms. Few studies have examined the im…

  • Smokers With Behavioral Health Comorbidity Should Be Designated a Tobacco Use Disparity Group

    Jill M Williams, Marc L Steinberg et al.•ARTICLE•American Journal of Public Health•2013•Cited by: 5•References: 58

    Smokers with co-occurring mental illness or substance use disorders are not designated a disparity group or priority population by most national public health and tobacco control groups. These smokers fulfill the criteria commonly used to identify groups that merit special attention: targeted marketing by the tobacco industry, high smoking prevalence rates, heavy economic and health burdens from tobacco, limited access to treatment, and longer du…

  • Smokers With Behavioral Health Comorbidity Should Be Designated a Tobacco Use Disparity Group

    Jill M Williams, Marc L Steinberg et al.•ARTICLE•American Journal of Public Health•2013•Cited by: 5•References: 58

    Smokers with co-occurring mental illness or substance use disorders are not designated a disparity group or priority population by most national public health and tobacco control groups. These smokers fulfill the criteria commonly used to identify groups that merit special attention: targeted marketing by the tobacco industry, high smoking prevalence rates, heavy economic and health burdens from tobacco, limited access to treatment, and longer du…

  • Smokers With Behavioral Health Comorbidity Should Be Designated a Tobacco Use Disparity Group

    Jill M Williams, Marc L Steinberg et al.•ARTICLE•American Journal of Public Health•2013•Cited by: 5•References: 58

    Smokers with co-occurring mental illness or substance use disorders are not designated a disparity group or priority population by most national public health and tobacco control groups. These smokers fulfill the criteria commonly used to identify groups that merit special attention: targeted marketing by the tobacco industry, high smoking prevalence rates, heavy economic and health burdens from tobacco, limited access to treatment, and longer du…

  • “A Blessing and a Curse

    Annette Kline, Anna Kline et al.•ARTICLE•Substance Use & Misuse•2020

    Background: To address the alarming rise in opioid overdose deaths, states have increased public access to the overdose reversal medication, naloxone. While some studies suggest that increased naloxone accessibility reduces opioid overdose deaths, others raise concerns about unintended consequences, such as increases in risky drug use and opioid re-use post-overdose to counter naloxone-induced withdrawal symptoms. Few studies have examined the im…

  • Predictors of intentional fentanyl use

    Open Access•Ralph Foglia, Nina Cooperman et al.•ARTICLE•International Journal of Drug…•2021

  • Opioid overdose in the age of fentanyl

    Open Access•Annette Kline, Anna Kline et al.•ARTICLE•International Journal of Drug…•2021

Medicine (4 works) · Internal Medicine (3 works) · Opioid (3 works) · Opioid Use Disorder Treatment (3 works) · Psychiatry (3 works) · Anesthesia (2 works) · Fentanyl (2 works) · Opioid overdose (2 works) · Pain Management and Opioid Use (2 works) · Prenatal Substance Exposure Effects (2 works)

Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae